![](/img/cover-not-exists.png)
A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma
Cohen, Jonathon B., Maddocks, Kami J., Huang, Ying, Christian, Beth A., Jaglowski, Samantha M., Flowers, Christopher R., Blum, Kristie A.Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2017.1289527
Date:
February, 2017
File:
PDF, 543 KB
english, 2017